-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Ddc8hHsajgdbax9ILvrCyQPzkgD0/i6d86bVq49ywyEL/QpkJ4du3+JZjtCB9xG6 7gs7YU39Dweh/bJaNSefBQ== 0000350737-04-000046.txt : 20041027 0000350737-04-000046.hdr.sgml : 20041027 20041027154357 ACCESSION NUMBER: 0000350737-04-000046 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20041026 ITEM INFORMATION: Other Events FILED AS OF DATE: 20041027 DATE AS OF CHANGE: 20041027 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OCEAN BIO CHEM INC CENTRAL INDEX KEY: 0000350737 STANDARD INDUSTRIAL CLASSIFICATION: SPECIALTY CLEANING, POLISHING AND SANITATION PREPARATIONS [2842] IRS NUMBER: 591564329 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-11102 FILM NUMBER: 041099493 BUSINESS ADDRESS: STREET 1: 4041 SW 47TH AVE CITY: FORT LAUDERDALE STATE: FL ZIP: 33314 BUSINESS PHONE: 9545876280 MAIL ADDRESS: STREET 1: 4041 SW 47TH AVE CITY: FT LAUDERDALE STATE: FL ZIP: 33028 FORMER COMPANY: FORMER CONFORMED NAME: STAR BRITE CORP DATE OF NAME CHANGE: 19841204 8-K 1 form8k-compensation.txt COMPENSATION-NOMINATING UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Act of 1934 Date of Report (Date of earliest event reported) October 26, 2004 OCEAN BIO-CHEM, INC. Florida 2-70197 59-1564329 -------- -------- ------------- (State or other jurisdiction (Commission File Number) IRS Employer Identi- of Incorporation) fication Number) 4041 S.W. 47 Avenue Fort Lauderdale, Florida 3314 (Address of Principal Executive Offices) (Zip Code) (954) 587-6280 (Registrant's telephone number, including area code) (Former name of Registrant, if changed since last report) N/A Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions: ( ) Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ( ) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ( ) Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ( ) Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Item 8.01 Other Events As of October 26, 2004, our president and Chief Executive Officer, Peter G. Dornau, was the beneficial owner of approximately 51% of our issued and outstanding common stock. Because he controls in excess of 50% of the voting power of our common stock, we fall within the "Controlled Company Exemption" provided by NASDAQ Rule 4350(c) exempting us from the NASDAQ requirement to have independent Nominating and Compensation Committees of our Board of Directors. Our Nominating and Compensation Committees are not independent. SIGNATURES Pursuant to the requirements of the Securities Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Ocean Bio-Chem, Inc. /s/ Peter G. Dornau ----------------------- Peter G. Dornau Chairman of the Board and Chief Executive Officer -----END PRIVACY-ENHANCED MESSAGE-----